BDTX - Wall Street Estimates - Black Diamond Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.2

-0.453 %

$ 124 M

Market Cap

-1.65

P/E

Price Target Average

545.45%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

15.73%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Black Diamond Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for BDTX of $14.2 , with forecasts ranging from a low of $11 to a high of $20 .

BDTX Lowest Price Target Wall Street Target

11 USD 400.00%

BDTX Average Price Target Wall Street Target

14.2 USD 545.45%

BDTX Highest Price Target Wall Street Target

20 USD 809.09%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free